Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

DCI Nurse Is Bright Spot For Patients

What does it take to be a great oncology nurse? Joey Misuraca, RN, the nurse manager on the 9100 unit of Duke University Hospital, where seriously ill blood cancer patients are treated, is clear. “What I’m looking for as I hire these new nurses is someone who’s coming out enthusiastic to learn;...

LeBlanc Receives International Clinical Impact Award

Thomas LeBlanc, MD , a practicing hematologic oncologist and palliative care physician at Duke Cancer Institute, recently received the 2018 European Association of Palliative Care (EAPC) Clinical Impact Award. The European Association for Palliative Care is a membership organization dedicated to...

Frith Named To Receive A Meritorious Service Award

Jennifer Frith, MSN, RN, OCN, NE-BC, who directs clinical operations for Inpatient Oncology and Adult Blood and Marrow and Cell Therapy (ABMT), was recently named to receive a 2018 Presidential Award, the highest honor given by Duke University to its faculty and staff. In a nomination sent to the...

Duke Cancer Institute Authorized To Offer Commercial CAR T-Cell Therapy  

On Jan. 31, Duke Cancer Institute joined a select group of medical centers across the country (34 to date) certified and trained to administer Yescarta, the first Food and Drug Administration-approved CAR T-cell therapy for the treatment of adult patients with certain types of relapsed or...

Caring House Gala To Honor Nelson Chao

Caring House will host its 27 Annual Gala on Saturday, Jan. 27. This year’s gala honors Hematologic Malignancies and Cellular division chief Nelson Chao, MD, MBA, the Donald D. and Elizabeth G. Cooke Cancer Research Professor. For more than 26 years Caring House has provided a home away from home...

DCI Investigators Showcase Research At ASH

Duke Cancer Institute researchers are attending the American Society of Hematology’s (ASH) 59th Annual Meeting & Exposition in Atlanta this week. Here are some highlights from the ASH meeting: Updated Prognostic Tools Needed in the Era of Novel Therapies for Chronic Lymphocytic Leukemia...

Heme Faculty Retreat Showcases Breadth Of Research

The Duke Division of Hematologic Malignancies and Cellular Therapy held their annual faculty retreat on Friday, Nov. 10, at the JB Duke Hotel on campus. It was an opportunity, said division chief Nelson Chao, MD, MBA, for faculty to share with each other the breadth and depth of ongoing basic and...

Making Pigs Fly? Investigators Up To The Challenge

When Duke Cancer Institute researcher Christopher Pirozzi, PhD, was an intern doing stem cell research in Australia, he spotted a child’s mobile of a pig with wings in one of the director’s offices. He said it embodied exactly what research meant to him — making the seemingly impossible, possible...

Sarantopoulos Named 2016 LLS Woman Of The Year

The Leukemia and Lymphoma Society's (LLS) annual Man & Woman of the Year fundraising campaign calls on Triangle community leaders to demonstrate gritty resolve in the quest to find a cure. At the close of this year’s ten-week campaign on April 30, Duke’s Stefanie Sarantopoulos, MD, PhD, was...

Duke Receives $10 Million to Continue Developing Blood-Based Radiation Test

Duke has received a $10.4 million contract from the Biomedical Advanced Research and Development Authority (BARDA), to continue research into the development of a blood test to measure radiation exposure. The test, which is now being developed under the leadership of Nelson Chao, MD, MBA, chief of...

October DCI Seminar Series (10.22.14)

The DCI Seminar Series is held during the Hematology Oncology Grand Rounds, usually on the fourth Wednesday of the month. The Seminar Series is hosted each month by a DCI research program and features a recognized scientific leader in that particular field.